Integrated Diagnostics Holdings plc Stock price

Equities

IDHC

JE00BLKGSR75

Healthcare Facilities & Services

Real-time Estimate Cboe Europe 09:37:14 2024-03-28 am EDT 5-day change 1st Jan Change
0.4 USD -1.60% Intraday chart for Integrated Diagnostics Holdings plc +2.70% +12.68%
Sales 2023 * 4.11B 86.9M Sales 2024 * 5.57B 118M Capitalization 11.52B 244M
Net income 2023 * 575M 12.16M Net income 2024 * 822M 17.38M EV / Sales 2023 * 2.84 x
Net Debt 2023 * 142M 3.01M Net cash position 2024 * 477M 10.08M EV / Sales 2024 * 1.98 x
P/E ratio 2023 *
20.7 x
P/E ratio 2024 *
12.6 x
Employees 6,718
Yield 2023 *
3.86%
Yield 2024 *
6.35%
Free-Float 51.88%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Integrated Diagnostics Holdings plc

1 day-1.60%
1 week+2.70%
Current month+17.99%
1 month+21.21%
3 months+11.11%
6 months+6.10%
Current year+12.68%
More quotes
1 week
0.37
Extreme 0.372
0.40
1 month
0.32
Extreme 0.317
0.43
Current year
0.29
Extreme 0.29
0.43
1 year
0.29
Extreme 0.29
0.63
3 years
0.29
Extreme 0.29
1.45
5 years
0.29
Extreme 0.29
1.45
10 years
0.29
Extreme 0.29
1.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 11-12-31
Director of Finance/CFO - Jan. 17
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman 66 15-01-11
Director/Board Member 58 15-01-11
Director/Board Member 59 14-12-22
More insiders
Date Price Change Volume
24-03-28 0.4 -1.60% 70
24-03-27 0.4065 +8.69% 49,036
24-03-26 0.374 -4.47% 45,265
24-03-25 0.3915 +0.38% 0
24-03-22 0.39 +0.13% 6,322

Delayed Quote London S.E., March 28, 2024 at 04:00 am EDT

More quotes
Integrated Diagnostics Holdings PLC is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology and others. The Company’s brands include Al Borg Scan, Al Mokhtabar, Ultralab, Biolab, Echo-Lab and others. It operates in approximately 552 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), electromyography (EMG), electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
19.21 EGP
Average target price
24.1 EGP
Spread / Average Target
+25.49%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Integrated Diagnostics Holdings plc - London S.E.